BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1268 related articles for article (PubMed ID: 32724277)

  • 1. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
    Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
    Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of IL23R, JAK2, and STAT3 gene polymorphisms and gene-gene interactions in Crohn's disease and ulcerative colitis in a Turkish population.
    Can G; Tezel A; Gürkan H; Tozkır H; Ünsal G; Soylu AR; Ümit HC
    Turk J Gastroenterol; 2016 Nov; 27(6):525-536. PubMed ID: 27852544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
    Cleynen I; Boucher G; Jostins L; Schumm LP; Zeissig S; Ahmad T; Andersen V; Andrews JM; Annese V; Brand S; Brant SR; Cho JH; Daly MJ; Dubinsky M; Duerr RH; Ferguson LR; Franke A; Gearry RB; Goyette P; Hakonarson H; Halfvarson J; Hov JR; Huang H; Kennedy NA; Kupcinskas L; Lawrance IC; Lee JC; Satsangi J; Schreiber S; Théâtre E; van der Meulen-de Jong AE; Weersma RK; Wilson DC; ; Parkes M; Vermeire S; Rioux JD; Mansfield J; Silverberg MS; Radford-Smith G; McGovern DP; Barrett JC; Lees CW
    Lancet; 2016 Jan; 387(10014):156-67. PubMed ID: 26490195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of interleukin 6 in pathogenesis of inflammatory bowel disease.
    Takac B; Mihaljević S; Stefanić M; Glavas-Obrovac L; Kibel A; Samardzija M
    Coll Antropol; 2014 Jun; 38(2):659-64. PubMed ID: 25145003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase-2 gene polymorphisms are associated with ulcerative colitis and Crohn's disease in Turkish Population.
    Can G; Tezel A; Gürkan H; Can H; Yılmaz B; Ünsal G; Soylu AR; Ümit HC
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):489-98. PubMed ID: 25744728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V
    Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory bowel disease: no association between allele combinations of the interleukin (IL) I beta and IL-I receptor antagonist gene polymorphisms.
    Hacker UT; Bidlingmaier C; Gomolka M; Keller E; Eigler A; Hartmann G; Folwaczny C; Fricke H; Albert E; Loeschke K; Endres S
    Eur J Clin Invest; 1998 Mar; 28(3):214-9. PubMed ID: 9568467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single nucleotide polymorphism in the STAT5 gene favors colonic as opposed to small-bowel inflammation in Crohn's disease.
    Connelly TM; Koltun WA; Berg AS; Hegarty JP; Brinton D; Deiling S; Poritz LS; Stewart DB
    Dis Colon Rectum; 2013 Sep; 56(9):1068-74. PubMed ID: 23929016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of T Helper 1 Cytokine Gene Single Nucleotide Polymorphisms with Ulcerative Colitis and Crohn's Disease.
    Ebrahimi Daryani N; Sadr M; Soltani S; Saghazadeh A; Moossavi S; Shahkarami S; Farhadi E; Rezaei N
    Dig Dis; 2019; 37(1):21-32. PubMed ID: 30134230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
    Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
    Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophil associated genes in the inflammatory bowel disease 4 region: correlation to inflammatory bowel disease revealed.
    Blom K; Rubin J; Halfvarson J; Törkvist L; Rönnblom A; Sangfelt P; Lördal M; Jönsson UB; Sjöqvist U; Håkansson LD; Venge P; Carlson M
    World J Gastroenterol; 2012 Nov; 18(44):6409-19; discussion p. 6417-8. PubMed ID: 23197886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of inflammatory bowel disease.
    Satsangi J; Parkes M; Jewell DP; Bell JI
    Clin Sci (Lond); 1998 May; 94(5):473-8. PubMed ID: 9682668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial occurrence and inheritance studies in inflammatory bowel disease.
    Binder V; Orholm M
    Neth J Med; 1996 Feb; 48(2):53-6. PubMed ID: 8819799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelations between interleukin-6, interleukin-1 beta, plasma C-reactive protein values, and in vitro C-reactive protein generation in patients with inflammatory bowel disease.
    Mazlam MZ; Hodgson HJ
    Gut; 1994 Jan; 35(1):77-83. PubMed ID: 8307455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
    van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymorphism of the microsatellites and tumor necrosis factor genes in chronic inflammatory bowel diseases].
    Heresbach D; Ababou A; Bourienne A; Alizadeh M; Quelvennec E; Pagenault M; Dabadie A; Berre NH; Campion JP; Launois B; Gosselin M; Genetet B; Bretagne JF; Semana G
    Gastroenterol Clin Biol; 1997; 21(8-9):555-61. PubMed ID: 9587492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor-alpha receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab.
    Pierik M; Vermeire S; Steen KV; Joossens S; Claessens G; Vlietinck R; Rutgeerts P
    Aliment Pharmacol Ther; 2004 Aug; 20(3):303-10. PubMed ID: 15274667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The -295T-to-C promoter polymorphism of the IL-16 gene is associated with Crohn's disease.
    Glas J; Török HP; Unterhuber H; Radlmayr M; Folwaczny C
    Clin Immunol; 2003 Mar; 106(3):197-200. PubMed ID: 12706406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.